Stem Cell

Phase 1Withdrawn

0 watching 0 views this week💤 Quiet

Hype Score

Development Stage

✓

Pre-clinical

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Neurological; Disorder, Nervous System

Conditions

Neurological; Disorder, Nervous System

Trial Timeline

Dec 1, 2008 → Dec 1, 2018

NCT ID

NCT02245776

About Stem Cell

Stem Cell is a phase 1 stage product being developed by Brain Biotech for Neurological; Disorder, Nervous System. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT02245776. Target conditions include Neurological; Disorder, Nervous System.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (8)

NCT ID	Phase	Status	Start	Completion	Indication
NCT02245724	Phase 1	Withdrawn	Sep 1, 2011	Sep 1, 2016	Mental Retardation
NCT02245711	Phase 1	Withdrawn	Dec 1, 2010	Jun 1, 2015	Limb Girdle Muscular Dystrophy
NCT02241434	Phase 1	Withdrawn	Jan 1, 2009	Jun 1, 2016	Duchenne Muscular Dystrophy
NCT02241928	Phase 1	Withdrawn	Jan 1, 2009	May 1, 2019	Muscular Dystrophy
NCT02245698	Phase 1	Withdrawn	Dec 1, 2008	Dec 1, 2018	Stroke
NCT02245776	Phase 1	Withdrawn	Dec 1, 2008	Dec 1, 2018	Neurological; Disorder, Nervous System
NCT02242071	Phase 1	Withdrawn	Dec 1, 2008	Sep 1, 2016	Amyotrophic Lateral Sclerosis
NCT01984814	Phase 2	Withdrawn	Dec 1, 2008	Aug 1, 2013	Amyotrophic Lateral Sclerosis

Other Products from Brain Biotech

FCYC+Conventional treatment + conventional treatmentApproved

Escitalopram + PlaceboApproved

Sinemet CR + Placebo oral capsuleApproved

MethylprednisoloneApproved

MethylphenidateApproved